Bailey Jeffrey Allen - Insider Non-Derivative Transactions at Aurinia Pharmaceuticals Inc. (AUPH) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Nov 21, 2025, Bailey Jeffrey Allen's relationship to Aurinia Pharmaceuticals Inc. (AUPH) is Director, and currently has 13,356 shares of Common Stock, and 22,775 shares of Common Shares.
The charts below show the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AUPH insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Bailey Jeffrey Allen - Insider Non-Derivative Transactions of AUPH Common Stock
Bailey Jeffrey Allen - Insider Non-Derivative Transactions of AUPH Common Shares
Bailey Jeffrey Allen - Insider Non-Derivative Transactions at AUPH
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 22, 2025 | F -- (Common Shares) | 2716 | 15.68 | 22775 |
| Nov 22, 2024 | Acquisition -- (Common Shares) | 12135 | 0 | 25491 |
| Nov 12, 2024 | Sell -- (Common Stock) | 4557 | 8.43 | 13356 |
| Nov 9, 2024 | M -- (Common Stock) | 17913 | 0 | 17913 |